PATENT CLAIM ANALYSIS

Application Number: 15989985
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "015200"]

Abstract:
The invention provides methods and materials for making and using variant serum albumin amino acid sequences which exhibit improved properties compared to wild type serum albumin sequences. The invention further provides methods and materials for making and using fusion proteins in which the variant serum albumin amino acid sequences are fused to a therapeutic or diagnostic agent, such as a therapeutic protein, or a functional fragment or variant thereof that maintains activity, and exhibits improved properties.

Claim (Index 6):
The method of  claim 5 , wherein VSA binds to FcRn with a K D  of less than 50 nM.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.7234
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13985227', '13578688', '14181339', '15915977', '15753947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7455323170522065
- 35 USC 102 Novelty (BERT): 0.5565901562695623
- Combined Prediction Score: 0.726638100973942
- Mean Citation Score: 294.638252
- Max Citation Score: 307.64963
- Similarity Product: 154.20080396107195

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test